MedLife, Romania’s largest private medical services provider, ended the first three months of this year with a pro-forma consolidated turnover of RON 196.8 million, up by 34 percent, compared to the same period last year, the financial report reads.
Clinics and hospitals account for 29.4 percent and 21.6 percent respectively, followed by the corporate and laboratory divisions with 20.2 percent and 17.8 percent respectively. This includes the Polisano acquisition. The results are in line with the initial estimates, according to company representatives.
”We follow the development and expansion strategy, and the results reflect what we estimated. We have already announced the first purchases this year, Solomed (a deal colncluded on May 14) and Ghencea Medical Center (ongoing transaction) and we continue to move forward in this segment. We are constantly investing in people and medical technology to strengthen the strongest private platforms of diagnosis and surgical treatment in Romania. At the same time, we are considering a new series of greenfield projects, but also the development of new business lines, “said Mihai Marcu, President and CEO of MedLife.
In addition to greenfield projects and acquisitions, the company is considering the possibility of limited investments in the next period for expansion in the neighboring countries of Romania, in Bulgaria, Hungary and Serbia.